CRNC vs. BDSX

In the year-to-date period, CRNC achieves a -12.36% return, which is significantly higher than BDSX's -62.72% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cerence Inc. (CRNC) and Biodesix, Inc. (BDSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CRNC Sharpe Ratio is -0.25, which is higher than the BDSX Sharpe Ratio of -0.93. The chart below compares the historical Sharpe Ratios of CRNC and BDSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CRNC nor BDSX has paid dividends to shareholders.

The maximum CRNC drawdown since its inception was -98.22%, roughly equal to the maximum BDSX drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for CRNC and BDSX. For additional features, visit the drawdowns tool.

Cerence Inc. (CRNC) has a higher volatility of 26.03% compared to Biodesix, Inc. (BDSX) at 18.99%. This indicates that CRNC's price experiences larger fluctuations and is considered to be riskier than BDSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cerence Inc. and Biodesix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.